Eli Lilly & Co. will pay a combined $1.42 billion -- including the largest criminal fine in history, $515 million -- to settle charges that it illegally marketed the anti-psychotic drug Zyprexa for off-label use, federal prosecutors announced Thursday. Zyprexa was approved by the FDA only as a treatment for schizophrenia and bipolar disorder, prosecutors said, but Lilly allegedly set out to market the drug to elderly patients for such conditions as dementia, agitation and generalized sleep disorder.
Eli Lilly to Pay $1.42 Billion to Settle Zyprexa Marketing Suits
The Legal Intelligencer
January 16, 2009